Researchers utilized five different machine learning approaches to accurately spot lymphedema—a negative side effect of breast cancer treatment—which may help detect it earlier and improve treatment.
Though many single-arm studies using "surrogate markers" have predicted CT screening can reduce lung cancer mortality by 80 percent, randomized clinical trials with larger population cohorts have found such screening has reduced mortality by less than 20 percent.
When one institution gave radiologists a programmable 13-button mouse over a two-day period, many preferred the non-conventional device over the traditional three-button variety, according to a study published in the Journal of Digital Imaging.
A groundbreaking new treatment that involves a magnetic metal “seed” and an MRI scanner could destroy deadly brain tumors in 10 minutes, according to a June 8 article in The Telegraph.
A team of researchers from Auburn University in Alabama believe art classes can have a meaningful impact on the brain—which may lead to a deeper understanding of cognitive conditions such as depression.
Biomodex, a Paris-based medical device company, announced last week that it plans to open its first 3D human organ printing factory in the U.S. within the year, according to a June 10 article in Newsweek.
In a letter to the U.S. Preventative Services Task Force (USPSTF), the American College of Radiology (ACR), the Lung Cancer Alliance and the Society of Thoracic Surgeons urged for objectivity in the upcoming review of the USPSTF’s lung cancer screening recommendations.
Affidea, the leading European provider of diagnostic imaging, outpatient and cancer care services, announced that 11 of its centers have been awarded "5 Stars" on the EuroSafe Wall by the European Society of Radiology.
First phase of Singapore’s Advanced Medicine Imaging Center provides accurate and timely diagnosis of cancer, plus an education center for medical training and scientific research collaborations.
In a blow to Medicare patients with metastatic cancers, the Centers for Medicare & Medicaid Services (CMS) announced it has rejected reimbursement coverage for 18F-sodium fluoride positron emission tomography (NaF PET) imaging.
